Home » Pharma News (page 17)

Pharma News

US FDA approves Semler Scientific’s next generation PAD testing system

US FDA approves Semler Scientific’s next generation PAD testing system The US Food and Drug Administration (FDA) has granted 510(k) marketing clearance for Semler Scientific’s next generation peripheral artery disease (PAD) testing system. The next generation system features convenience and ease of use characteristics along with compatibility to electronic medical record systems for easy accessibility of data. The system was ... Read More »

GSK becomes partner in new global fund to accelerate dementia research

GSK becomes partner in new global fund to accelerate dementia research GSK today announced it will be a key partner, with an investment of $25m (approx £17m), in a pioneering new global fund for dementia research. The Dementia Discovery Fund, which is being established by the UK government with initial commitments totalling $100m, brings together leading pharmaceutical companies, the UK ... Read More »

Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics

Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics NEW DELHI: Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics, taking its holding in the company to 100 per cent. Lupin had earlier acquired ... Read More »

Ranbaxy merger: Sun Pharma readies new leadership team

Sun Pharma readies new leadership team Taking forward its acquisition of Ranbaxy Laboratories  , Sun Pharma  has put in place a team of top executives, including Dilip Shanghvi’s son Aalok Shanghvi, to lead the businesses of both the organisations. While the leadership team is comprised mainly from the representatives of Sun Pharma, it also has executives from Ranbaxy, drawing upon ... Read More »

Suven Life Sciences gets patents for neuro-degenerative drug

Suven Life Sciences gets patents for neuro-degenerative drug  Pharmaceutical firm Suven Life SciencesBSE 0.45 % has been granted a patent each by Eurasia and Israel for drug used in the treatment of neuro-degenerative diseases. Neuro-degenerative ailments include Alzheimer’s disease, Schizophrenia and Parkinson’s disease. In a BSE filing, the company said it has received “grant of one product patent from Eurasia ... Read More »

Sun Pharma, SPARC hit new high on USFDA nod for ELEPSIA XR

Sun Pharma, SPARC hit new high on USFDA nod for ELEPSIA XR Shares of Sun Pharmaceutical Industries and Sun PharmaAdvanced Research Company (SPARC) have touched their respective record high after SPARC announced that the U.S. Food and Drug Administration (FDA) have approved its new drug application (NDA) for ELEPSIA XR (Levetiracetam extended-release tablets 1000 mg and 1500 mg). The product ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes